Neuren Pharmaceuticals LimitedASX: NEU

First subject commences Neurens Rett syndrome Phase 2 trial

Apr 7, 2016 at 5:09 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment